Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

DRA004162

Type of data: NGS (ChIP-seq)
Access criteria: Unrestricted-access
Total data volume: 28.9 GB
File formats: FASTQ
Research: hum0044
Date published: 2016-02-22
Date modified: 2016-02-23
DDBJ Search: DRA004162 (opens in a new tab)

Analysis method

ChIP-seq

Materials and participants: ED cell line derived from 1 patient with ATL; Health status
Affected
Subject count
1 (Individual)
Sample description: Chromatin DNA extracted from ED; Tumor / normal
Tumor
Sample provider: N/A
Experimental method: ChIP-seq
Target: N/A
Reagent kit: NEBNext Ultra DNA Library Prep Kit for Illumina
Fragmentation: Bioruptor USD-200 (Diagenode)
Platform: Illumina NextSeq 500
Read type: Paired-end
Read length: 300 bp
Data use policy: NBDC data sharing policy (JGAP000001)